Article
China approves AstraZeneca's drug for respiratory syncytial virus
Rating:
0.0
Views:
42
Likes:
1
Library:
1
A medicine to prevent serious respiratory disease developed by AstraZeneca has been approved in China, an increasingly important market for the pharma group
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value